DEA could reclassify marijuana to a less restrictive category – a drug policy expert weighs the pros and cons

The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden’s call to reclassify marijuana, moving it from the tightly controlled Schedule I category that…

Mounting research points to health harms from cannabis, THC and CBD use during pregnancy, adolescence and other periods of rapid development

Cannabis is a widely used psychoactive drug worldwide, and its popularity is growing: The U.S. market for recreational cannabis sales could surpass US$72 billion by 2023. As of early 2023,…